PubRank

R Rosenquist

Author PubWeight™ 34.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 2007 1.64
2 The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia. Leukemia 2006 1.47
3 Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients. Leukemia 2009 1.34
4 Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia 2013 1.31
5 NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia. Leukemia 2012 1.27
6 A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 2009 1.27
7 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2012 1.23
8 Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations. Leukemia 2010 1.19
9 Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer 2012 1.12
10 Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases. Leukemia 2011 1.10
11 Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia. Br J Cancer 2007 1.05
12 Determination of IGHV gene mutational status in chronic lymphocytic leukemia: bioinformatics advances meet clinical needs. Leukemia 2007 1.04
13 Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer. J Med Genet 2002 1.01
14 CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood 2001 0.99
15 Antigen receptor stereotypy across B-cell lymphoproliferations: the case of IGHV4-59/IGKV3-20 receptors with rheumatoid factor activity. Leukemia 2011 0.98
16 Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas. Leukemia 2005 0.92
17 Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution. Leukemia 2010 0.92
18 Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. Pharmacogenomics J 2010 0.92
19 Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. Br J Cancer 2003 0.86
20 Tibial component fixation in knee arthroplasty. Clin Orthop Relat Res 1986 0.82
21 Micromotion of conventionally cemented all-polyethylene tibial components in total knee replacements. A roentgen stereophotogrammetric analysis of migration and inducible displacement. Arch Orthop Trauma Surg 1987 0.81
22 Coexistence of trisomies of chromosomes 12 and 19 in chronic lymphocytic leukemia occurs exclusively in the rare IgG-positive variant. Leukemia 2011 0.81
23 Impact of TP53 mutation and 17p deletion in mantle cell lymphoma. Leukemia 2011 0.81
24 Clonal rearrangements in childhood and adult precursor B acute lymphoblastic leukemia: a comparative polymerase chain reaction study using multiple sets of primers. Eur J Haematol 1999 0.81
25 The novel NF-κB inhibitor IMD-0354 induces apoptosis in chronic lymphocytic leukemia. Blood Cancer J 2011 0.81
26 Detailed clonality analysis of relapsing precursor B acute lymphoblastic leukemia: implications for minimal residual disease detection. Leuk Res 2001 0.80
27 A one-year multicenter clinical trial of pilocarpine gel. Am J Ophthalmol 1984 0.80
28 Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br J Cancer 2000 0.80
29 The BCL-2 promoter (-938C>A) polymorphism does not predict clinical outcome in chronic lymphocytic leukemia. Leukemia 2007 0.79
30 Absence of H2AX gene mutations in B-cell leukemias and lymphomas. Leukemia 2005 0.79
31 Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays. Cancer Lett 2008 0.78
32 Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia. Leukemia 2005 0.78
33 Hemodynamic changes during ventricular pacing in patients with complete heart block and aortic and mitral valvular heart disease. Am Heart J 1975 0.77
34 Comparative analysis of detection systems for evaluation of PCR amplified immunoglobulin heavy-chain gene rearrangements. Diagn Mol Pathol 1997 0.76
35 Reply to 'Male preponderance in chronic lymphocytic leukemia utilizing IGHV1-69.' When size of the sample matters. Leukemia 2007 0.75
36 Early carcinoma of the prostate: comparison of stages A and B. J Urol 1976 0.75
37 A technique for removal of filariasis of the anterior chamber. Ophthalmic Surg 1988 0.75
38 Whole-genome-amplified DNA as a source for mutational analysis underestimates the frequency of mutations in pediatric acute myeloid leukemia. Leukemia 2012 0.75